Long, G., Chen, H., Wu, M., Li, Y., Gao, L., Huang, S., . . . Xia, W. (2020). Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways. Front Pharmacol.

Long, Guangfeng, Hongbing Chen, Mengying Wu, Yuanyuan Li, Ling Gao, Songming Huang, Yue Zhang, Zhanjun Jia, och Weiwei Xia. "Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity By Targeting Antiapoptotic and Antioxidative Pathways." Front Pharmacol 2020.

Long, Guangfeng, et al. "Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity By Targeting Antiapoptotic and Antioxidative Pathways." Front Pharmacol 2020.